Structural Heart Closure Devices – Market Insights – Asia Pacific
Although the global COVID-19 pandemic negatively impacted the Asia Pacific structural heart closure device market in 2020, strong prepandemic growth trends in the PFO and LAA segments helped to sustain positive overall procedure volume and market growth for the year, and the market has subsequently shown strong recovery. Going forward, the market will continue to expand through 2032, supported by continued robust growth in the well-established Australian market, expanding evidence demonstrating the safety and efficacy of transcatheter and epicardial structural heart closure procedures, the introduction of new devices, and growing competition from and the strong presence of domestic manufacturers offering low-cost products in the large and expanding Chinese market.
This Medtech 360 Report provides comprehensive data and analysis on the state of the structural heart closure device market in Asia Pacific from 2019 through 2032.
The Asia Pacific structural heart closure device market will be impacted by the COVID-19 pandemic in the early years of the forecast period.
How did the COVID-19 pandemic impact the global structural heart closure device, and to what extent has it recovered?
When is the structural heart closure market expected to revert to pre-pandemic growth?
The Asia Pacific market for structural heart closure devices will grow moderately through 2032.
What are upcoming developments in the structural heart closure device market?
What ongoing clinical trials will impact the structural heart closure device market?
How are clinical developments across the globe impacting the Asia Pacific structural heart closure device market?
Which new devices have been launched over the past year and are expected to launch in the Asia Pacific market?
The LAA closure device segment represents a significant market opportunity for manufacturers in the structural heart closure device space.
What strategies will MNCs adopt to compete with the domestic players in the Asia Pacific market?
Who are the new players in the LAA closure device market?
How are the domestic players able to maintain their position in the Asia Pacific market?
Table of contents
- Structural Heart Closure Devices - Market Insights - Asia Pacific
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- Structural Heart Closure Device Market
- Market Highlights
- Key Content Updates
- Asia Pacific Structural Heart Closure Device Market Drivers
- Asia Pacific Structural Heart Closure Device Market Limiters
- Structural Heart Closure Device Market, by Procedure Type, Asia Pacific (USD), 2019u20132032
- Structural Heart Closure Device Market, by Country, Asia Pacific (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Structural Heart Closure Procedures, by Procedure Type, Asia Pacific, 2019u20132032
- Structural Heart Closure Procedures, by Country, Asia Pacific, 2019u20132032
- Structural Heart Closure Device Market, by Procedure Type, Asia Pacific (USD), 2019u20132032
- Structural Heart Closure Device Market, by Country, Asia Pacific (USD), 2019u20132032
- Market Shares
- Competitive Insights
- Market Developments
- Market Highlights
- Congenital Heart Defect Closure Device Market
- Market Highlights
- Key Content Updates
- Asia Pacific Congenital Heart Defect Closure Device Market Drivers
- Asia Pacific Congenital Heart Defect Closure Device Market Limiters
- Congenital Heart Defect Closure Device Market, by Indication, Asia Pacific (USD), 2019u20132032
- Congenital Heart Defect Closure Device Market, by Country, Asia Pacific (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Congenital Heart Defect Closure Procedures, by Indication, Asia Pacific, 2019u20132032
- Congenital Heart Defect Closure Procedures, by Country, Asia Pacific, 2019u20132032
- Congenital Heart Defect Closure Device Market, by Indication, Asia Pacific (USD), 2019u20132032
- Congenital Heart Defect Closure Device Market, by Country, Asia Pacific (USD), 2019u20132032
- Atrial Septal Defect Closure Device Market
- Patent Ductus Arteriosus Closure Device Market
- Ventricular Septal Defect Closure Device Market
- Australia
- China
- India
- South Korea
- Market Shares
- Competitive Insights
- Market Highlights
- Patent Foramen Ovale Closure Device Market
- Left Atrial Appendage Closure Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- LAA Closure Procedures, by Technique, Asia Pacific, 2019u20132032
- LAA Closure Procedures, by Country, Asia Pacific, 2019u20132032
- LAA Closure Device Market, by Technique, Asia Pacific (USD), 2019u20132032
- LAA Closure Device Market, by Country, Asia Pacific (USD), 2019u20132032
- Endocardial Left Atrial Appendage Closure Devices
- Epicardial Left Atrial Appendage Closure Devices
- Australia
- China
- India
- South Korea
- Market Shares
- Competitive Insights
- Appendix
Anusha Naik is a member of the Cardiovascular Medtech Insights team at Clarivate, specializing in the heart valve device market. Anusha holds a Bachelor’s degree in Pharmaceutical Sciences from Goa College of Pharmacy, Goa and a Master’s degree in Pharmaceutical Quality Assurance from the Manipal Academy of Higher Education, Manipal.
